GEODE CAPITAL MANAGEMENT, LLC - ONCOMED PHARMACEUTICALS INC ownership

ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 68 filers reported holding ONCOMED PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 30.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ONCOMED PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$205,000
-20.5%
197,855
-43.0%
0.00%
Q4 2018$258,000
-4.4%
347,126
+172.3%
0.00%
Q3 2018$270,000
-0.4%
127,480
+8.7%
0.00%
Q2 2018$271,000
-27.3%
117,3300.0%0.00%
Q1 2018$373,000
-22.5%
117,3300.0%0.00%
Q4 2017$481,000
-14.6%
117,330
-5.8%
0.00%
Q3 2017$563,000
+36.0%
124,5690.0%0.00%
Q2 2017$414,000
-72.7%
124,569
-24.5%
0.00%
-100.0%
Q1 2017$1,518,000
+18.8%
164,888
-0.6%
0.00%0.0%
Q4 2016$1,278,000
-19.3%
165,963
+19.8%
0.00%0.0%
Q3 2016$1,583,000
+20.3%
138,506
+29.5%
0.00%0.0%
Q2 2016$1,316,000
+27.5%
106,982
+4.8%
0.00%0.0%
Q1 2016$1,032,000
-55.2%
102,089
-0.1%
0.00%0.0%
Q4 2015$2,302,000
+52.0%
102,162
+11.9%
0.00%0.0%
Q3 2015$1,514,000
-28.6%
91,317
-3.1%
0.00%0.0%
Q2 2015$2,119,000
+15.5%
94,190
+32.3%
0.00%0.0%
Q1 2015$1,834,000
+22.1%
71,174
+3.1%
0.00%0.0%
Q4 2014$1,502,000
+29.9%
69,027
+13.0%
0.00%0.0%
Q3 2014$1,156,000
+35.4%
61,112
+66.6%
0.00%0.0%
Q2 2014$854,000
-17.9%
36,681
+18.6%
0.00%0.0%
Q1 2014$1,040,000
+19.4%
30,921
+4.7%
0.00%0.0%
Q4 2013$871,000
+105.9%
29,522
+6.8%
0.00%
Q3 2013$423,00027,6440.00%
Other shareholders
ONCOMED PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 1,839,730$16,944,0004.17%
BVF INC/IL 1,760,489$16,214,0002.76%
Iguana Healthcare Management, LLC 490,000$4,513,0002.23%
Broadfin Capital, LLC 300,000$2,763,0000.34%
TURNER INVESTMENTS LLC 38,083$351,0000.23%
Birchview Capital, LP 34,689$319,0000.18%
Piermont Capital Management Inc. 52,195$481,0000.12%
Cannell & Co. 331,296$3,051,0000.11%
NJ State Employees Deferred Compensation Plan 48,000$442,0000.08%
DISCIPLINED GROWTH INVESTORS INC /MN 324,350$2,987,0000.07%
View complete list of ONCOMED PHARMACEUTICALS INC shareholders